{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-220607","form_type":"8-K","ticker":"PVLA","cik":"0001583648","company_name":"PALVELLA THERAPEUTICS, INC.","filed_at":"2026-05-13T11:30:15+00:00","discovered_at":"2026-05-13T11:35:00.272589+00:00","generated_at":"2026-05-13T11:39:32.229817+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Palvella Therapeutics approved to uplist to Nasdaq Global Market on May 13","bullets":["Nasdaq approval for transfer from Capital Market to Global Market received May 11, 2026.","Effective at open of business on May 13, 2026; ticker PVLA unchanged.","Company will trade on the more prestigious Nasdaq Global tier."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-220607","json":"https://secwatch.observer/filing/0001193125-26-220607.json","markdown":"https://secwatch.observer/filing/0001193125-26-220607.md","text":"https://secwatch.observer/filing/0001193125-26-220607.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583648/000119312526220607/0001193125-26-220607-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583648/000119312526220607/pvla-20260511.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-13T11:39:32.229817+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}